Dr Harry Antoniades – Reader and Consultant Hepatologist working in Digestive Diseases, has received substantial funding with Imperial College sponsoring the study to run a 3-year multi centre clinical trial called R-RID. The trial will be looking at the use of selective intestinal decontamination to reduce infections in patients with liver failure.
Due to start on October the trial will be run in conjunction with The Royal Liverpool University Hospitals, University Hospitals Birmingham, Chelsea & Westminster Hospital and Firmly Health NHS Trusts. The two big collaborating liver centres are Birmingham Liver Unit and Liverpool.